The economic impact of prostate cancer screening and treatment.
DiSantostefano
Rachael L
RL
Epidemiology, GlaxoSmithKline, USA. rdisantostefano@nc.rr.com
Lavelle
John P
JP
D005189:False Positive Reactions; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000191:economics*; D011237:Predictive Value of Tests; D017430:Prostate-Specific Antigen / Q000032:analysis*; D011471:Prostatic Neoplasms / Q000191:economics* / Q000453:epidemiology / Q000628:therapy*
D017430:Prostate-Specific Antigen